Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Award for Immuno-Oncology 2024 Recipient Announced

05 Nov 2024

The ESMO Award for Immuno-Oncology 2024 is presented to Ton N. Schumacher in recognition of his outstanding contribution to the field of cancer immunology. Schumacher is Principal Investigator at The Netherlands Cancer Institute and Oncode Institute, and Professor of Immunotechnology at Leiden University, Netherlands.

His laboratory research focuses on the development of novel technologies with which T cell responses can be measured or manipulated, and the subsequent use of these technologies to understand how T cells can recognise and destroy human cancer. Key outputs of his research are his work describing the role of the cancer neoantigens that are formed as a consequence of DNA damage in human cancer immunotherapy and his work providing the first evidence for the superior activity of the, now widely explored, concept of neoadjuvant immune checkpoint blockade. Schumacher is recipient of, amongst others, the Queen Wilhelmina Cancer Research Award, Meyenburg Cancer Research Award, William B. Coley Award, and Louis Jeantet Prize for Medicine.

Schumacher will deliver his award lecture on Wednesday, 11 December 2024 at the ESMO Immuno-Oncology Congress 2024 Opening session.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.